Home » Yale Study Uses 454 Sequencing to Detect Drug-Resistant HIV Variants

Yale Study Uses 454 Sequencing to Detect Drug-Resistant HIV Variants

Jun 18, 2007
NEW YORK (GenomeWeb News) - 454 Life Sciences said on Friday that it has collaborated with the Yale University School of Medicine to use its sequencing technology to identify previously undetectable drug-resistant HIV variants at an early stage.
 
The study authors said that current genotyping technology can only detect resistance mutations at levels of approximately 20 percent or greater, but sequencing is able to detect resistance mutations at the 1 percent level.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

French Funding Agency Head Resigns

The president of France's National Research Agency has resigned, according to Nature News.

Right to Try Versus Clinical Trials

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

This Week in PNAS

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

'Lifestyle Zone'

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.

What's Popular?

In Clinical Sequencing

  1. Helix Launches Genomics Marketplace Hoping to Entice Consumers to Repeatedly Query DNA

  2. China's Direct Genomics Demonstrates Single-Molecule Sequencing of E. Coli

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.